Literature DB >> 23399728

Artificial neural networks and prostate cancer--tools for diagnosis and management.

Xinhai Hu1, Henning Cammann, Hellmuth-A Meyer, Kurt Miller, Klaus Jung, Carsten Stephan.   

Abstract

Artificial neural networks (ANNs) are mathematical models that are based on biological neural networks and are composed of interconnected groups of artificial neurons. ANNs are used to map and predict outcomes in complex relationships between given 'inputs' and sought-after 'outputs' and can also be used find patterns in datasets. In medicine, ANN applications have been used in cancer diagnosis, staging and recurrence prediction since the mid-1990s, when an enormous effort was initiated, especially in prostate cancer detection. Modern ANNs can incorporate new biomarkers and imaging data to improve their predictive power and can offer a number of advantages as clinical decision making tools, such as easy handling of distribution-free input parameters. Most importantly, ANNs consider nonlinear relationships among input data that cannot always be recognized by conventional analyses. In the future, complex medical diagnostic and treatment decisions will be increasingly based on ANNs and other multivariate models.

Entities:  

Mesh:

Year:  2013        PMID: 23399728     DOI: 10.1038/nrurol.2013.9

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  99 in total

Review 1.  Artificial neural networks for diagnosis and prognosis in prostate cancer.

Authors:  Guido Schwarzer; Martin Schumacher
Journal:  Semin Urol Oncol       Date:  2002-05

Review 2.  Avoiding pitfalls in applying prediction models, as illustrated by the example of prostate cancer diagnosis.

Authors:  Henning Cammann; Klaus Jung; Hellmuth-A Meyer; Carsten Stephan
Journal:  Clin Chem       Date:  2011-09-15       Impact factor: 8.327

3.  An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.

Authors:  Alexandre R Zlotta; Mesut Remzi; Peter B Snow; Claude C Schulman; Michael Marberger; Bob Djavan
Journal:  J Urol       Date:  2003-05       Impact factor: 7.450

4.  Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routine.

Authors:  Thorsten H Ecke; Peter Bartel; Steffen Hallmann; Stefan Koch; Jürgen Ruttloff; Henning Cammann; Michael Lein; Mark Schrader; Kurt Miller; Carsten Stephan
Journal:  Urol Oncol       Date:  2010-04-03       Impact factor: 3.498

5.  Machine learning for improved pathological staging of prostate cancer: a performance comparison on a range of classifiers.

Authors:  Olivier Regnier-Coudert; John McCall; Robert Lothian; Thomas Lam; Sam McClinton; James N'dow
Journal:  Artif Intell Med       Date:  2011-12-27       Impact factor: 5.326

Review 6.  Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.

Authors:  Andrew W Roddam; Michael J Duffy; Freddie C Hamdy; Anthony Milford Ward; Julietta Patnick; Christopher P Price; Janet Rimmer; Cathie Sturgeon; Peter White; Naomi E Allen
Journal:  Eur Urol       Date:  2005-09       Impact factor: 20.096

7.  Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy.

Authors:  Giovanni Lughezzani; Massimo Lazzeri; Alessandro Larcher; Giuliana Lista; Vincenzo Scattoni; Andrea Cestari; Nicoló Maria Buffi; Vittorio Bini; Giorgio Guazzoni
Journal:  J Urol       Date:  2012-08-15       Impact factor: 7.450

8.  Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies.

Authors:  Carsten Stephan; Henning Cammann; Axel Semjonow; Eleftherios P Diamandis; Leon F A Wymenga; Michael Lein; Pranav Sinha; Stefan A Loening; Klaus Jung
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

9.  Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening.

Authors:  Patrik Finne; Ralf Finne; Chris Bangma; Jonas Hugosson; Matti Hakama; Anssi Auvinen; Ulf-Håkan Stenman
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

10.  Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

Authors:  Donna Pauler Ankerst; Jack Groskopf; John R Day; Amy Blase; Harry Rittenhouse; Brad H Pollock; Cathy Tangen; Dipen Parekh; Robin J Leach; Ian Thompson
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

View more
  22 in total

1.  External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer detection.

Authors:  Vito Lorusso; Boukary Kabre; Geraldine Pignot; Nicolas Branger; Andrea Pacchetti; Jeanne Thomassin-Piana; Serge Brunelle; Nicola Nicolai; Gennaro Musi; Naji Salem; Emanuele Montanari; Ottavio de Cobelli; Gwenaelle Gravis; Jochen Walz
Journal:  World J Urol       Date:  2022-03-06       Impact factor: 4.226

2.  Machine Learning for the Prediction of Synchronous Organ-Specific Metastasis in Patients With Lung Cancer.

Authors:  Huan Gao; Zhi-Yi He; Xing-Li Du; Zheng-Gang Wang; Li Xiang
Journal:  Front Oncol       Date:  2022-05-13       Impact factor: 5.738

3.  Development and head-to-head comparison of machine-learning models to identify patients requiring prostate biopsy.

Authors:  Shuanbao Yu; Jin Tao; Biao Dong; Yafeng Fan; Haopeng Du; Haotian Deng; Jinshan Cui; Guodong Hong; Xuepei Zhang
Journal:  BMC Urol       Date:  2021-05-16       Impact factor: 2.264

Review 4.  Artificial intelligence in brachytherapy: a summary of recent developments.

Authors:  Susovan Banerjee; Shikha Goyal; Saumyaranjan Mishra; Deepak Gupta; Shyam Singh Bisht; Venketesan K; Kushal Narang; Tejinder Kataria
Journal:  Br J Radiol       Date:  2021-04-29       Impact factor: 3.629

5.  Neural network cascade optimizes microRNA biomarker selection for nasopharyngeal cancer prognosis.

Authors:  Wenliang Zhu; Xuan Kan
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

6.  Classification of Paediatric Inflammatory Bowel Disease using Machine Learning.

Authors:  E Mossotto; J J Ashton; T Coelho; R M Beattie; B D MacArthur; S Ennis
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

7.  Modeling using clinical examination indicators predicts interstitial lung disease among patients with rheumatoid arthritis.

Authors:  Yao Wang; Wuqi Song; Jing Wu; Zhangming Li; Fengyun Mu; Yang Li; He Huang; Wenliang Zhu; Fengmin Zhang
Journal:  PeerJ       Date:  2017-02-21       Impact factor: 2.984

8.  Automated Classification of Circulating Tumor Cells and the Impact of Interobsever Variability on Classifier Training and Performance.

Authors:  Carl-Magnus Svensson; Ron Hübler; Marc Thilo Figge
Journal:  J Immunol Res       Date:  2015-10-04       Impact factor: 4.818

9.  The superior fault tolerance of artificial neural network training with a fault/noise injection-based genetic algorithm.

Authors:  Feng Su; Peijiang Yuan; Yangzhen Wang; Chen Zhang
Journal:  Protein Cell       Date:  2016-08-09       Impact factor: 14.870

10.  Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis.

Authors:  Haifeng Ding; Jia Meng; Wei Zhang; Zhangming Li; Wenjing Li; Mingming Zhang; Ying Fan; Qiujun Wang; Yina Zhang; Lihong Jiang; Wenliang Zhu
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.